InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength

Go back to InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
Gilead Sciences (NASDAQ: GILD) Delayed: 152.21 --0 (-0%)
Previous Close $152.21    52 Week High $108.63 
Open $152.21    52 Week Low $71.39 
Day High $152.21    P/E 84.09 
Day Low $152.21    EPS $1.81 
Volume 2,862       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 49.70 --0 (-0%)
Previous Close $49.70    52 Week High $45.58 
Open $49.70    52 Week Low $37.82 
Day High $49.70    P/E N/A 
Day Low $49.70    EPS $0.00 
Volume 75,964       

InterMune, Inc. (NASDAQ: ITMN) Delayed: 73.89 --0 (-0%)
Previous Close $73.89    52 Week High $74.24 
Open $1.07    52 Week Low $10.95 
Day High $73.89    P/E N/A 
Day Low $73.89    EPS $-2.67 
Volume 5       

NOVARTIS AG (NYSE: NVS) Delayed: 146.88 --0 (-0%)
Previous Close $146.88    52 Week High $89.15 
Open $146.88    52 Week Low $69.84 
Day High $146.88    P/E N/A 
Day Low $146.88    EPS $0.00 
Volume 3,779